New developments in heart failure: role of endothelin and the use of endothelin receptor antagonists.

Damodhar P. Suresh; Sumant Lamba; William T. Abraham

doi:10.1054/JCAF.2000.20560

New developments in heart failure: role of endothelin and the use of endothelin receptor antagonists.

Damodhar P. Suresh
, Sumant Lamba
, William T. Abraham

University of Cincinnati Academic Health Center

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of Cardiac Failure
Volume	6
Issue number	4
DOIs	https://doi.org/10.1054/JCAF.2000.20560
State	Published - Dec 1 2000

Disciplines

Pharmacology
Medicine and Health Sciences

Access to Document

10.1054/JCAF.2000.20560License: Unspecified

Cite this

@article{8b67a2e2c8fa42cea710da5c1ec70d95,

title = "New developments in heart failure: role of endothelin and the use of endothelin receptor antagonists.",

author = "Suresh, \{Damodhar P.\} and Sumant Lamba and Abraham, \{William T.\}",

note = "Despite conventional therapy, there is still much room for improvement in the prognosis of patients with chronic systolic heart failure. Evidence supports a role for endothelin-1 (ET-1), a potent vasoconstrictor, in the pathophysiology of heart failure. Given its potentially deleterious effects, the ...",

year = "2000",

month = dec,

day = "1",

doi = "10.1054/JCAF.2000.20560",

language = "American English",

volume = "6",

journal = "Journal of Cardiac Failure",

number = "4",

}

TY - JOUR

T1 - New developments in heart failure: role of endothelin and the use of endothelin receptor antagonists.

AU - Suresh, Damodhar P.

AU - Lamba, Sumant

AU - Abraham, William T.

N1 - Despite conventional therapy, there is still much room for improvement in the prognosis of patients with chronic systolic heart failure. Evidence supports a role for endothelin-1 (ET-1), a potent vasoconstrictor, in the pathophysiology of heart failure. Given its potentially deleterious effects, the ...

PY - 2000/12/1

Y1 - 2000/12/1

UR - http://www.ncbi.nlm.nih.gov/pubmed/11145761

U2 - 10.1054/JCAF.2000.20560

DO - 10.1054/JCAF.2000.20560

M3 - Article

VL - 6

JO - Journal of Cardiac Failure

JF - Journal of Cardiac Failure

IS - 4

ER -

New developments in heart failure: role of endothelin and the use of endothelin receptor antagonists.

Disciplines

Access to Document

Other files and links

Cite this